Early arrival did not ensure the early acquisition of intravenous thrombosis for acute ischemic stroke during the COVID-19 pandemic
- PMID: 36974385
- PMCID: PMC10175972
- DOI: 10.1002/brb3.2977
Early arrival did not ensure the early acquisition of intravenous thrombosis for acute ischemic stroke during the COVID-19 pandemic
Abstract
Background: Intravenous thrombolysis (IVT) in acute ischemic stroke (AIS) is a time-dependent treatment with a narrow therapeutic time window, in which the time delay could result from the deadline effect.
Methods: One hospital-based cohort was recruited to detect the factors contributing to the deadline effect, where patients with the deadline effect were defined as those who were presented with the onset-to-door time (ODT) in the first 50%, while the door-to-needle time (DNT) was in the last quartile. DNT (in-hospital delay) was further subdivided into several time intervals [door-to-examination time (DET), door-to-imaging time (DIT), door-to-laboratory time (DLT), and decision-making time (DMT) of the patients or their proxies.
Results: A total of 186 IVT cases were enrolled, of which 17.2% (32/186) suffered a delay of the deadline effect. The median age was 66 years, and 35.5% were female. Baseline characteristics were similar between the two groups (all p > .05). For the comparisons of the time intervals, DIT (26 versus 15 min, p = .001) was significantly longer in the group with deadline effect, while the differences of DET, DLT, DMT, and ONT did not reach statistical significance (all p > .05). Upon multivariable adjustment in the binary logistic regression model, longer DIT [odds ratio (OR), 1.076; 95% confidence interval (CI), 1.036-1.118; p < .001], and history of coronary heart disease (OR, 3.898; 95%CI, 1.415-10.735; p = .008) were independently associated with deadline effect in the binary logistic regression model, while admitted in the working day (OR, 0.674; 95%CI, 0.096-0.907; p = .033), and having medical insurance (OR, 0.350; 95% CI, 0.132-0.931; p = .035) were negatively associated with the deadline effect.
Conclusions: A speed-safety tradeoff phenomenon from the deadline effect was observed in 17.2% of IVT cases during the COVID-19 pandemic, where longer DIT contributed a lot to this time delay. Patients without medical insurance, or admitted in official holidays were more likely to experience a delay of the deadline effect.
Keywords: behavioral paradigms; cerebrovascular diseases; stress; stroke.
© 2023 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Intravenous thrombolysis for acute ischemic stroke during two COVID-19 outbreaks in China: Wuhan pandemic and Beijing pandemic.BMC Neurol. 2023 May 25;23(1):206. doi: 10.1186/s12883-023-03211-9. BMC Neurol. 2023. PMID: 37231485 Free PMC article.
-
Delayed Stroke Treatment during COVID-19 Pandemic in China.Cerebrovasc Dis. 2021;50(6):715-721. doi: 10.1159/000517075. Epub 2021 Jul 9. Cerebrovasc Dis. 2021. PMID: 34247153 Free PMC article.
-
The effects of the coronavirus disease pandemic on intravenous thrombolytic therapy among patients with acute ischemic stroke in Dalian, China.BMC Neurol. 2023 Jan 9;23(1):10. doi: 10.1186/s12883-023-03053-5. BMC Neurol. 2023. PMID: 36624392 Free PMC article.
-
Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.CNS Neurol Disord Drug Targets. 2023;22(10):1493-1506. doi: 10.2174/1871527322666221004113752. CNS Neurol Disord Drug Targets. 2023. PMID: 36200200
-
Intravenous thrombolysis prior to mechanical thrombectomy in large vessel occlusions.Ann Neurol. 2019 Sep;86(3):395-406. doi: 10.1002/ana.25544. Epub 2019 Jul 22. Ann Neurol. 2019. PMID: 31282044
Cited by
-
The global burden and attributable risk factor analysis of age-related macular degeneration in 204 countries and territories, 1990-2021.Eye (Lond). 2025 Jun;39(9):1860-1867. doi: 10.1038/s41433-025-03774-6. Epub 2025 Mar 28. Eye (Lond). 2025. PMID: 40155536
References
-
- Chinese medical association neurological credit association, department of cerebrovascular diseases in Chinese medical association neurological credit Committee . (2015). Chinese guidelines for diagnosis and management of acute ischemic stroke. Chinese Journal of Neurology, 48(4), 246–257.
-
- Daou, B. , Deprince, M. , D'ambrosio, R. , Tjoumakaris, S. , Rosenwasser, R. H. , Ackerman, D. J. , Bell, R. , Tzeng, D. L. , Ghobrial, M. , Fernandez, A. , Shah, Q. , Gzesh, D. J. , Murphy, D. , Castaldo, J. E. , Mathiesen, C. , Pineda, M. C. , & Jabbour, P. (2015). Pennsylvania comprehensive stroke center collaborative: Statement on the recently updated IV rt‐PA prescriber information for acute ischemic stroke. Clinical Neurology and Neurosurgery, 139, 264–268. 10.1016/j.clineuro.2015.10.010 - DOI - PubMed
-
- Fonarow, G. C. , Zhao, X. , Smith, E. E. , Saver, J. L. , Reeves, M. J. , Bhatt, D. L. , Xian, Y. , Hernandez, A. F. , Peterson, E. D. , & Schwamm, L. H. (2014). Door‐to‐needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA, 311(16), 1632–1640. 10.1001/jama.2014.3203 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical